| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(19960822)69:4<247::AID-IJC1>3.0.CO;2-X |
| P698 | PubMed publication ID | 8797862 |
| P50 | author | Robert Zeillinger | Q39409373 |
| Charles Theillet | Q55664894 | ||
| P2093 | author name string | F Courjal | |
| Robert Zeillinger | |||
| Charles Theillet | |||
| Paul Speiser | |||
| P Speiser | |||
| D Katsaros | |||
| Dionisios Katsaros | |||
| Frank Courjal | |||
| G Louason | |||
| Geneviève Louason | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| overexpression | Q61643320 | ||
| cancer research | Q3421914 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 247-253 | |
| P577 | publication date | 1996-08-01 | |
| 1996-08-22 | |||
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors | |
| Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection ofcyclin D1 in breast andcyclin E in ovarian tumors | |||
| P478 | volume | 69 |
| Q73572568 | 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization |
| Q38464166 | A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas |
| Q30390024 | A multilevel data integration resource for breast cancer study |
| Q33241980 | AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines |
| Q73780160 | Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix |
| Q37160444 | Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation. |
| Q74201921 | Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome |
| Q80807833 | Amplification of 11q13 in ovarian carcinoma |
| Q30986520 | Amplification of growth regulatory genes in intraductal breast cancer is associated with higher nuclear grade but not with the progression to invasiveness. |
| Q28188140 | Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines |
| Q40867507 | Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells |
| Q35624792 | Breaking the cycle: An insight into the role of ERα in eukaryotic cell cycles |
| Q37344785 | Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity |
| Q33822845 | Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer |
| Q36114935 | Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q |
| Q74635303 | Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas |
| Q101574333 | Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells |
| Q35792001 | Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma |
| Q28385752 | Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome |
| Q40794379 | Cyclin D1 and human neoplasia |
| Q73662616 | Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas |
| Q24644847 | Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 |
| Q28280284 | Cyclin D3 expression in normal, reactive and neoplastic tissues |
| Q33538420 | Cyclins and breast cancer |
| Q24802591 | Cyclins in breast cancer: too much of a good thing |
| Q34511086 | Distinct expression pattern and post-transcriptional regulation of cell cycle genes in the glandular epithelia of avian ovarian carcinomas |
| Q38489881 | Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping |
| Q34358413 | Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features |
| Q24633900 | E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes |
| Q53742241 | Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. |
| Q44039602 | Estrogen receptor gene amplification occurs rarely in ovarian cancer |
| Q36641066 | Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells |
| Q35398444 | Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions |
| Q79915423 | Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival |
| Q54353413 | Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients. |
| Q73102796 | Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance |
| Q33521103 | Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells |
| Q36925229 | Inherited and acquired alterations in development of breast cancer. |
| Q40524990 | Involvement of estrogen receptor beta in ovarian carcinogenesis |
| Q47278984 | Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma |
| Q57287496 | MYEOV: A candidate gene for DNA amplification events occurring centromeric toCCND1in breast cancer |
| Q36796448 | Mammalian interphase cdks: dispensable master regulators of the cell cycle |
| Q40773704 | Microarray analysis of gene expression mirrors the biology of an ovarian cancer model. |
| Q34987420 | Molecular alterations in sporadic breast cancer |
| Q34130548 | Molecular mechanisms underlying ErbB2/HER2 action in breast cancer |
| Q34554750 | Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis |
| Q45196334 | Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization |
| Q40902305 | Overexpression of p21 protein in radiation-transformed mouse 10T(1/2) cell clones |
| Q44416382 | Overexpression of p21, cyclin E and decreased expression of p27 in DMBA (7, 12‐dimethylbenzanthracene)‐induced rat ovarian carcinogenesis |
| Q36869444 | PKCiota promotes ovarian tumor progression through deregulation of cyclin E. |
| Q43269857 | PPFIA1 and CCND1 are frequently coamplified in breast cancer |
| Q38946190 | Parkin and mitophagy in cancer. |
| Q34086636 | Prognostic biomarkers in ovarian cancer |
| Q36291799 | Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter |
| Q33966444 | Regulation of the functional interaction between cyclin D1 and the estrogen receptor |
| Q35158463 | Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development |
| Q33888942 | Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase |
| Q39009613 | Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies |
| Q51587602 | Specific overexpression of cyclin E·CDK2 in early preinvasive and primary breast tumors in female ACI rats induced by estrogen. |
| Q38652190 | The 'Pushmi-Pullyu' of DNA REPAIR: Clinical Synthetic Lethality |
| Q38066149 | The 11q13-q14 amplicon: clinicopathological correlations and potential drivers |
| Q33558545 | Transcriptional repression by RB-E2F and regulation of anchorage-independent survival |
| Q28253011 | Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples |
Search more.